# Roche to acquire PathAI for AI-driven digital pathology

Roche entered into a definitive merger agreement to acquire PathAI, a US-based digital pathology and AI-powered technology company. The acquisition is expected to close in the second half of 2026.

- Type: Acquisition
- Announced: 2026-05-07
- Where: United States
- Status: announced
- Products: digital pathology AI platform, image management system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Roche Holdings Inc](https://endata.com/companies/16415.md) (acquirer)
- [PathAI](https://endata.com/companies/91785.md) (target)

## Sources

- [roche.com](https://www.roche.com/media/releases/med-cor-2026-05-07), 2026-05-07: "Digital pathology has the potential to improve precision diagnosis of cancer and enable physicians to offer better tailored treatment regimens."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.